Your missing piece for Imaging Core Lab Services
“I have been working in the clinical research field for approximately 12 years, and a recent project required the use of a specialty imaging core laboratory to assist in two global cardiac SPECT phase 3 protocols. Cardiovascular Imaging Technologies offered the full suite of services from site selection to blinded reads and I was most impressed by their extensive knowledge, ability to collaborate and meet timelines. As an example, CVIT worked tirelessly to review site qualifications and perform site training in order to launch both global programs on time! I appreciated CVIT’s team approach and dedication to assist us in meeting goals.”
Tracey A. Roberts, BSN
Senior Director of Clinical Trial Management
Synthetic Biologics, Inc.
Figure 1: Early Phase 1 and 2a studies are pivotal for the future of a new product. Dosage, study protocol and typical results essential for propelling a product forward can be extracted when the right analysis program is applied.CVIT’s imaging core laboratory can work with your experts to use your exploratory data to identify critical pharmacokinetic parameters for designing optimal Phase 2B and Phase 3 clinical trials.
Cardiovascular Imaging Technologies has global experience in providing imaging core laboratory services. These studies have covered a broad range of study endpoints including pharmacokinetics, protocol design, endpoint design, sensitivity and specificity and non-inferiority.
|Secure electronic data transmittal||Yes||Yes|
|Phase 1–4 Capabilities||Yes||Yes|
|Expert Scientific Team||?||Yes|
|Novel Protocol Development||?||Yes|
|Uses World Experts as Blinded Readers||?||Yes|
|Site Training by Industry Experts||?||Yes|
CVIT scientists are engaged at every step of your study to ensure the scientific integrity of your study.